SciSparc partners with Clearmind to develop psychedelic therapies

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SciSparc partners with Clearmind to develop psychedelic therapies

To read the full story on Seeking Alpha, click here.

SciSparc (NASDAQ:SPRC)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more SciSparc Charts.

SciSparc (NASDAQ:SPRC)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more SciSparc Charts.

SciSparc Ltd News

SciSparc to Acquire AutoMax
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
Monday 18 March 2024 (1 month ago) • GlobeNewswire Inc.

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

More SciSparc Ltd News Articles

S&P ASX 300 Metals and M...

Westpac Banking

Woodside Petroleum

Newcrest Mining

National Australia Bank

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions